U.S. market Closed. Opens in 15 hours 47 minutes

MRVI | Maravai LifeSciences Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue288.94M883.00M799.24M284.10M143.14M123.83M
Cost of Revenue148.74M168.96M140.56M79.65M66.85M60.77M
Gross Profit140.20M714.04M658.68M204.45M76.29M63.07M
Operating Expenses171.85M147.63M115.28M103.55M51.98M45.69M
Selling, General & Admin151.39M129.26M100.06M94.25M48.35M41.19M
Research & Development17.28M18.37M15.22M9.30M3.63M4.50M
Other Operating Expenses3.18M-358.00K279.00K-7.47M118.00K87.00K
Operating Income-31.65M574.22M554.64M67.60M23.99M16.44M
Other Expenses / Income649.38M-22.74M-23.88M-22.09M-29.84M-32.93M
Before Tax Income617.74M551.47M530.76M81.70M-5.85M-16.50M
Income Tax Expenses756.11M60.81M61.52M2.88M-652.00K417.00K
Net Income-119.03M490.66M469.25M76.89M-5.20M-17.73M
Interest Expenses45.89M20.41M30.26M30.74M29.96M27.40M
Basic Shares Outstanding131.92M131.54M114.79M96.65M96.65M88.97M
Diluted Shares Outstanding131.92M255.32M257.80M96.65M96.65M88.97M
EBITDA712.41M609.99M585.78M138.27M48.19M33.25M
EBITDA Margin246.56%69.08%73.29%48.67%33.67%26.85%
EBIT682.97M571.89M561.02M110.51M24.11M10.09M
EBIT Margin236.37%64.77%70.19%38.90%16.84%8.14%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙